KNSL vs SKWD: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: SKWD is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. KNSL and SKWD share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined KNSL and SKWD exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Kinsale Capital Group is a specialty property and casualty insurer focused entirely on the U.S. excess and surplus (E&S) lines market, the segment that handles hard-to-place commercial risks the standard admitted market will not write. It underwrites a broad spread of commercial lines (property, excess casualty, small business, construction, allied health, professional liability, commercial auto, and environmental) plus a small personal-lines book, distributing exclusively through independent brokers across all 50 states. Its structural edge is a proprietary technology platform that lets it run an expense ratio near 20 percent, well below peers, which supports consistently profitable underwriting and returns on equity in the high-20s percent range.

Full KNSL guide

Skyward writes commercial property and casualty insurance in niches most carriers do not staff for. The US business is organised into nine underwriting divisions, each with dedicated leadership: Accident & Health, Captives, Credit & Surety, Energy Solutions, Global Agriculture, Global Property, Professional Lines, Specialty Programs and Transactional E&S. Second-quarter 2026 gross written premiums from those divisions came to ~$667.9M, up 14.1% year over year, with Global Agriculture nearly doubling to ~$111.9M and Accident & Health up 57.8% to ~$95.5M, while Captives, Energy Solutions and Global Property each contracted by mid-teens percentages. Management calls the approach "Rule Our Niche", and the intended consequence is that close to half the book sits in lines that do not track the property catastrophe cycle. On January 1, 2026 the company closed a ~$559.1M purchase of Apollo Group Holdings, paid for with ~$371.1M of cash and 3,679,332 Skyward shares valued at $51.11 each. Apollo underwrites through Syndicates 1969 and 1971 with its own capital and provides managing agency services to nine Lloyd's syndicates in total, which hands Skyward a fee stream on premium it does not carry: ~$318.1M of fee-generating gross written premium in the quarter.

Full SKWD guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• KNSL drivers: Structural low-cost advantage; E&S market tailwind.
• SKWD drivers: Apollo turns an underwriter into a fee earner as well; Nine divisions that grow and shrink on their own schedules.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The largest single risk is valuation: a premium multiple leaves little room for disappointment, so any slowdown in growth or margin can compress the stock. For SKWD, the largest exposure is reserve adequacy.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick KNSL if you believe its drivers more; SKWD if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the KNSL and SKWD guides.

KNSL. Kinsale trades at a premium to most specialty insurers, recently around the high-teens on trailing earnings and several times book value, which reflects its sector-leading return on equity and low combined ratio rather than a bargain price. Q1 2026 net income rose to about $112.6 million ($4.88 per diluted share) as the combined ratio improved year over year. Figures are approximate and drawn from company releases; they move with each quarterly report.

SKWD. A screener's 1.3x price-to-sales figure carries almost no signal for SKWD, because insurance revenue is premium the company has already promised to pay claims against. The multiple that carries information is price to book, and at ~2.0x the stock sits well below the ~4x to 5x that the market has awarded the fastest-growing US excess and surplus underwriters, and above the ~1.3x to 1.5x typical of carriers whose returns hover near their cost of capital. On tangible book the gap narrows, since ~$471.2M of the equity base is now goodwill and intangibles from Apollo.

Headline figures (approximate, July 2026): KNSL shows revenue (ttm) ~$1.85B, gross written premiums (fy2025) ~$2.0B, net income (fy2025) ~$503.6M, combined ratio (q1 2026) ~77.4%; SKWD shows revenue (ttm) ~$1.73B for the twelve months to June 30, 2026, against ~$1.42B in fiscal 2025, ~$1.15B in 2024 and ~$886M in 2023. The 2026 half-year figure of ~$965.4M includes Apollo for the first time, alongside ~$878.5M of net earned premium, ~$57.8M of net investment income, ~$22.7M of underwriting fee income and ~$3.9M of commission and fee income., earnings and operating earnings Second-quarter 2026 net income of ~$49.0M, or ~$1.07 per diluted share, and operating income of ~$59.2M, or ~$1.30 per diluted share, up 46% year over year. First-half net income was ~$98.8M (~$2.17 diluted) and operating income ~$116.1M (~$2.55 diluted). Full-year 2025 delivered ~$170.0M of net income (~$4.07 diluted) and ~$167.4M of adjusted operating income (~$4.00). Trailing twelve-month diluted EPS is ~$4.30., underwriting metrics Combined ratio of 89.5% in the second quarter of 2026 (62.3% loss, 27.2% expense), 87.6% excluding 1.9 points of catastrophe loss, versus 89.3% for full-year 2025 and 92.3% for 2024. By segment, Skyward Specialty ran 86.9% and Apollo 97.6%. Gross written premiums were ~$740.6M in the quarter and ~$2,166.2M for full-year 2025; ceded written premium of ~$254.9M in the quarter left ~$485.6M net written and ~$444.5M net earned, a 65.6% net retention., book value and returns Book value per share of $28.55 at June 30, 2026, up 14.6% from $24.92 at December 31, 2025, which had itself risen 26% during 2025. Fully diluted book value per share was $27.20 and tangible shareholders' equity ~$861.9M, or roughly $19.41 per share. Annualized return on equity was 15.7% for the quarter and 17.3% for the half; annualized operating ROE was 19.0% and 20.4%, and operating return on tangible equity 28.2% and 26.0%..

KNSL and SKWD are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined KNSL and SKWD exposure against your real portfolio. It is not an investment adviser.